Cargando…
Correction: Alectinib (CH5424802) antagonizes ABCB1- and ABCG2-mediated multidrug resistance in vitro, in vivo and ex vivo
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7338346/ https://www.ncbi.nlm.nih.gov/pubmed/32555512 http://dx.doi.org/10.1038/s12276-020-0453-6 |
_version_ | 1783554653266378752 |
---|---|
author | Yang, Ke Chen, Yifan To, Kenneth Kin Wah Wang, Fang Li, Delan Chen, Likun Fu, Liwu |
author_facet | Yang, Ke Chen, Yifan To, Kenneth Kin Wah Wang, Fang Li, Delan Chen, Likun Fu, Liwu |
author_sort | Yang, Ke |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-7338346 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-73383462020-07-16 Correction: Alectinib (CH5424802) antagonizes ABCB1- and ABCG2-mediated multidrug resistance in vitro, in vivo and ex vivo Yang, Ke Chen, Yifan To, Kenneth Kin Wah Wang, Fang Li, Delan Chen, Likun Fu, Liwu Exp Mol Med Author Correction Nature Publishing Group UK 2020-06-17 /pmc/articles/PMC7338346/ /pubmed/32555512 http://dx.doi.org/10.1038/s12276-020-0453-6 Text en © The Author(s) 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Author Correction Yang, Ke Chen, Yifan To, Kenneth Kin Wah Wang, Fang Li, Delan Chen, Likun Fu, Liwu Correction: Alectinib (CH5424802) antagonizes ABCB1- and ABCG2-mediated multidrug resistance in vitro, in vivo and ex vivo |
title | Correction: Alectinib (CH5424802) antagonizes ABCB1- and ABCG2-mediated multidrug resistance in vitro, in vivo and ex vivo |
title_full | Correction: Alectinib (CH5424802) antagonizes ABCB1- and ABCG2-mediated multidrug resistance in vitro, in vivo and ex vivo |
title_fullStr | Correction: Alectinib (CH5424802) antagonizes ABCB1- and ABCG2-mediated multidrug resistance in vitro, in vivo and ex vivo |
title_full_unstemmed | Correction: Alectinib (CH5424802) antagonizes ABCB1- and ABCG2-mediated multidrug resistance in vitro, in vivo and ex vivo |
title_short | Correction: Alectinib (CH5424802) antagonizes ABCB1- and ABCG2-mediated multidrug resistance in vitro, in vivo and ex vivo |
title_sort | correction: alectinib (ch5424802) antagonizes abcb1- and abcg2-mediated multidrug resistance in vitro, in vivo and ex vivo |
topic | Author Correction |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7338346/ https://www.ncbi.nlm.nih.gov/pubmed/32555512 http://dx.doi.org/10.1038/s12276-020-0453-6 |
work_keys_str_mv | AT yangke correctionalectinibch5424802antagonizesabcb1andabcg2mediatedmultidrugresistanceinvitroinvivoandexvivo AT chenyifan correctionalectinibch5424802antagonizesabcb1andabcg2mediatedmultidrugresistanceinvitroinvivoandexvivo AT tokennethkinwah correctionalectinibch5424802antagonizesabcb1andabcg2mediatedmultidrugresistanceinvitroinvivoandexvivo AT wangfang correctionalectinibch5424802antagonizesabcb1andabcg2mediatedmultidrugresistanceinvitroinvivoandexvivo AT lidelan correctionalectinibch5424802antagonizesabcb1andabcg2mediatedmultidrugresistanceinvitroinvivoandexvivo AT chenlikun correctionalectinibch5424802antagonizesabcb1andabcg2mediatedmultidrugresistanceinvitroinvivoandexvivo AT fuliwu correctionalectinibch5424802antagonizesabcb1andabcg2mediatedmultidrugresistanceinvitroinvivoandexvivo |